Revealing the Complex Interplay Between Cancer and Cardiovascular Disease: Can Cardiac Magnetic Resonance Lead the Way?

Revealing the Complex Interplay Between Cancer and Cardiovascular Disease: Can Cardiac Magnetic Resonance Lead the Way?

Bibliographic Details
Main Authors:	Daniel H. Chen, Arjun K. Ghosh
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials cancer cardio‐oncology cardiotoxicity cardiovascular disease cardiovascular magnetic resonance imaging
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.021424

Similar Items

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy
by: Iwan Harries, MBBCh, et al.
Published: (2020-06-01)

Current Evidence on the Benefit of Exercise in Cancer Patients: Effects on Cardiovascular Mortality, Cardiotoxicity, and Quality of Life
by: Núria Coma, et al.
Published: (2023-06-01)

A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors
by: Nathanya Baez Hernandez, et al.
Published: (2024-04-01)

Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity
by: Angel T. Chan, et al.
Published: (2021-04-01)

Cardio‐Oncology at the Beginning of a New Decade
by: Isabella M. Grumbach
Published: (2020-01-01)

Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy
by: Michael G. Fradley, et al.
Published: (2021-05-01)

Current perspectives of cardio‐oncology: Epidemiology, adverse effects, pre‐treatment screening and prevention strategies
by: Jakub Bychowski, et al.
Published: (2023-07-01)

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging
by: Shawn C. Pun, et al.
Published: (2016-05-01)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
by: Biniyam G. Demissei, et al.
Published: (2020-01-01)

Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology
by: Samaneh Zandifar, et al.
Published: (2024-01-01)

Risk Stratification and Management of Arterial Hypertension and Cardiovascular Adverse Events Related to Cancer Treatments: An Oncology Network from Piedmont and Aosta Valley (North-Western Italy) Consensus Document
by: Giulia Mingrone, et al.
Published: (2021-01-01)

Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy
by: Giv Heidari-Bateni, et al.
Published: (2021-10-01)

Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer
by: Alessandra Ghigo, et al.
Published: (2023-05-01)

Cardio-oncology: the new frontier of clinical and preventive cardiology
by: Sara Paris, et al.
Published: (2020-06-01)

Common biological processes and mutual crosstalk mechanisms between cardiovascular disease and cancer
by: Hanwei Gao, et al.
Published: (2024-11-01)

Overview of short and long-term management of cardiovascular disease in the cancer patient: Research-driven guidance for the clinician
by: Mary Branch
Published: (2023-12-01)

Evolving field of cardio-oncology
by: Guo Li, et al.
Published: (2023-04-01)

Understanding the biological mechanisms of cancer treatment-induced cardiac toxicity
by: Eric H. Yang, et al.
Published: (2022-06-01)

Heart failure from cancer therapy: can we prevent it?
by: Matthias Totzeck, et al.
Published: (2019-08-01)

Predictive Factors of Therapy-Related Cardiovascular Events in Patients with Lymphoma Receiving Anthracyclines
by: Alberto Lopez-Garcia, et al.
Published: (2024-04-01)

Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity
by: Xinxin Zhang, et al.
Published: (2022-10-01)

Cardiovascular Effects of CAR T Cell Therapy
by: Bénédicte Lefebvre, MD, et al.
Published: (2020-06-01)

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
by: Joachim Alexandre, et al.
Published: (2020-09-01)

Nomogram for Predicting Risk of Cancer Therapy–Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
by: Anthony F. Yu, et al.
Published: (2023-10-01)

Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies
by: Xiaoting Wei, et al.
Published: (2022-07-01)

Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
by: Michael G. Fradley, et al.
Published: (2017-07-01)

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies
by: Meiqi Miao, et al.
Published: (2025-03-01)

Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
by: Linda Piras, et al.
Published: (2024-11-01)

Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope
by: Rishabh Mittal, et al.
Published: (2023-01-01)

Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01)

Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
by: Anthony F. Yu, et al.
Published: (2023-03-01)

Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer
by: Yinghui Wang, et al.
Published: (2022-03-01)

Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population
by: Stacey Doran, et al.
Published: (2023-06-01)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
by: Nikhil Agrawal, et al.
Published: (2019-03-01)

Atrial Fibrillation in Cancer Patients: Who is at Risk?
by: Yu. A. Vasyuk, et al.
Published: (2022-01-01)

Genetic factors in the pathogenesis of cardio-oncology
by: Yalong Qi, et al.
Published: (2024-08-01)

Current status and research hotspots of cardio-oncology based on bibliometrics
by: LI Mengjuan, LIU Ying, ZHANG Yanli, LIU Mengyao, XUE Yanan, SU Liping, ZHANG Xiujie, SHI Tieying, FANG Fengqi, LIU Jiwei, XIA Yunlong
Published: (2022-10-01)

Cardio-Oncology in Iran: Cardio-toxicity Registry
by: Azin Alizadehasl, et al.
Published: (2022-08-01)

The Establishment of the Nordic Cardio-Oncology Society
by: Agneta Månsson Broberg, MD, PhD, et al.
Published: (2020-06-01)